Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart H Cohen

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Science Advances|October 12, 2023
First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibodyNegar Omidvari, Terry Jones, Pat M Price, et al.
Infection Control and Hospital Epidemiology|September 13, 2023
Assessing past versus present severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection: A survey of criteria for discontinuing precautions in asymptomatic patients testing positive on admissionShruti K Gohil, Annabelle De St Maurice, Deborah S Yokoe, et al.
Infection Control and Hospital Epidemiology|July 4, 2020
Investigation of nosocomial SARS-CoV-2 transmission from two patients to healthcare workers identifies close contact but not airborne transmission eventsDerek J Bays, Minh-Vu H Nguyen, Stuart H Cohen, et al.
Critical Care Explorations|July 19, 2021
Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial CohortChristopher J Colombo, Rhonda E Colombo, Ryan C Maves, et al.
Blood|March 10, 2012
Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infectionSarah K Browne, Rifat Zaman, Elizabeth P Sampaio, et al.
Infection Control and Hospital Epidemiology|July 21, 2021
Real-world impact of vaccination on coronavirus disease 2019 (COVID-19) incidence in healthcare personnel at an academic medical centerSarah E Waldman, Jason Y Adams, Timothy E Albertson, et al.
JAMA Internal Medicine|September 9, 2015
Overdiagnosis of Clostridium difficile Infection in the Molecular Test EraChristopher R Polage, Clare E Gyorke, Michael A Kennedy, et al.
Plos One|June 24, 2021
SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC DavisDavid A Coil, Timothy Albertson, Shefali Banerjee, et al.
The Journal of Infectious Diseases|August 2, 2025
Comparability of gastrointestinal microbiome and bile acid profiles in patients with first or multiply recurrent Clostridioides difficile infectionJessica A Bryant, Timothy J Straub, Darrell S Pardi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2023
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based TherapeuticCharles S Berenson, Bret Lashner, Louis Y Korman, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Science Advances|October 12, 2023
First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibodyNegar Omidvari, Terry Jones, Pat M Price, et al.
Infection Control and Hospital Epidemiology|September 13, 2023
Assessing past versus present severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection: A survey of criteria for discontinuing precautions in asymptomatic patients testing positive on admissionShruti K Gohil, Annabelle De St Maurice, Deborah S Yokoe, et al.
Infection Control and Hospital Epidemiology|July 4, 2020
Investigation of nosocomial SARS-CoV-2 transmission from two patients to healthcare workers identifies close contact but not airborne transmission eventsDerek J Bays, Minh-Vu H Nguyen, Stuart H Cohen, et al.
Critical Care Explorations|July 19, 2021
Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial CohortChristopher J Colombo, Rhonda E Colombo, Ryan C Maves, et al.
Blood|March 10, 2012
Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infectionSarah K Browne, Rifat Zaman, Elizabeth P Sampaio, et al.
Infection Control and Hospital Epidemiology|July 21, 2021
Real-world impact of vaccination on coronavirus disease 2019 (COVID-19) incidence in healthcare personnel at an academic medical centerSarah E Waldman, Jason Y Adams, Timothy E Albertson, et al.
JAMA Internal Medicine|September 9, 2015
Overdiagnosis of Clostridium difficile Infection in the Molecular Test EraChristopher R Polage, Clare E Gyorke, Michael A Kennedy, et al.
Plos One|June 24, 2021
SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC DavisDavid A Coil, Timothy Albertson, Shefali Banerjee, et al.
The Journal of Infectious Diseases|August 2, 2025
Comparability of gastrointestinal microbiome and bile acid profiles in patients with first or multiply recurrent Clostridioides difficile infectionJessica A Bryant, Timothy J Straub, Darrell S Pardi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2023
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based TherapeuticCharles S Berenson, Bret Lashner, Louis Y Korman, et al.
Pageof 8